Liquidia LQDA
NASDAQ LQDA
$68.51 +0.83 (+1.23%)
As of: Sep 9, 2026 · 1:47 PM EDT

Liquidia (LQDA) Research & Development (2020 - 2026)

Liquidia (LQDA) posted Research & Development of $17.2 million for Q2 2026, up 36.7% on a QoQ basis from $12.6 million in Q1 2026, and up 185.4% year-over-year from $6.0 million in Q2 2025.

Analysis

Liquidia (LQDA) Research & Development (2020 - 2026) Analysis & Trends

Liquidia has reported Research & Development for 7 years, with the latest figure at $17.2 million in Q2 2026.

  • On a quarterly basis, Research & Development rose 185.4% year-over-year to $17.2 million in Q2 2026; TTM through Jun 2026 was $56.0 million, a 35.53% increase from a year earlier, with the FY2025 full-year figure at $39.3 million, down 17.9% from the prior year.
  • Research & Development was $17.2 million for Q2 2026 at Liquidia, up from $12.6 million in the prior quarter.
  • The five-year high for Research & Development was $17.7 million in Q2 2023, with the low at $4.5 million in Q3 2022.
  • Average Research & Development over 5 years is $10.0 million, with a median of $9.4 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Research & Development jumped 239.05% in 2023, then plunged 46.76% in 2024.
  • Over 5 years, Research & Development stood at $5.0 million in 2022, then jumped by 157.82% to $12.8 million in 2023, then advanced by 28.42% to $16.5 million in 2024, then advanced by 2.84% to $16.9 million in 2025, then gained by 1.42% to $17.2 million in 2026.
  • The last three Research & Development figures came in at $17.2 million (Q2 2026), $12.6 million (Q1 2026), and $16.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 3.65 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 2.34 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -2.85 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 2.81 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -2.60 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 394.92 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 516.95 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 146.30 Mn
10 Liquidia 6.09 Bn 5.81 Bn 160.92 Mn 17.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.18 Mn
Mar 31, 2026 12.57 Mn
Dec 31, 2025 16.94 Mn
Sep 30, 2025 9.35 Mn
Jun 30, 2025 6.02 Mn
Mar 31, 2025 6.97 Mn
Dec 31, 2024 16.48 Mn
Sep 30, 2024 11.89 Mn
Jun 30, 2024 9.42 Mn
Mar 31, 2024 10.06 Mn
Dec 31, 2023 12.83 Mn
Sep 30, 2023 7.44 Mn
Jun 30, 2023 17.70 Mn
Mar 31, 2023 5.28 Mn
Dec 31, 2022 4.98 Mn
Sep 30, 2022 4.51 Mn
Jun 30, 2022 5.22 Mn
Mar 31, 2022 4.73 Mn
Dec 31, 2021 5.38 Mn
Sep 30, 2021 4.49 Mn